AlphaVax, Inc.Research Triangle Park, NC United States
Company Description
AlphaVax wants to be a top dog among vaccine makers. The company is developing new vaccines for cancers and infectious diseases such as HIV/AIDS, Ebola, influenza, and other viral maladies. AlphaVax relies on a proprietary alphavaccine system that genetically alters diseased cells and transforms them into a vaccine when they attempt to replicate. Its technology could be used to develop preventative vaccines and therapeutic vaccines. Its pipeline consists of early-stage candidates. AlphaVax receives funding through partnerships and grants.The company was founded in 1998 by Robert Johnston, Nancy Davis, and Jonathan Smith, AlphaVax's chief scientific officer.
| 2 Triangle Dr. | Phone: 919-595-0400 | http://www.alphavax.com |
| Research Triangle Park, NC 27709 | Fax: 919-595-0401 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
AlphaVax, Inc. Rankings
Executives
| 18 executives listed for AlphaVax, Inc.'s Research Triangle Park, NC location. | ||
| VP Regulatory, Quality, and Clinical Operations | Lynn Baird | |
|---|---|---|
Financials
| Company Type | PrivateHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 80 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on AlphaVax, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
